Corticosteroid resistance in mild asthma: Markers of persistent inflammation

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 5, 1999, Pages 457-462

  Matsuse, Hiroto ^a   Shimoda, Terufumi ^a   Matsuo, Nobuko ^a   Obase, Yasushi ^a   Asai, Sadahiro ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sasebo Shiritsu Sogo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 5; METHACHOLINE; PREDNISOLONE;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SPIROMETRY;

EID: 0033049160     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62721-4     Document Type: Article

References (30)

1. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-1026.
2. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981;36:5759.
3. Barnes PJ. Effect of corticosteroid on airway hyperresponsiveness. Am Rev Respir Dis 1990;141:870-76.
4. Schwartz H, Lowell F, Melby J. Steroid resistance in bronchial asthma. Ann Intern Med 1968;69:493-499.
5. Carmichael J, Paterson IC, Diaz P, et al. Corticosteroid resistance in chronic asthma. Br Med J Clin Res 1981;282: 1419-1422.
6. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma. Am Rev Respir Dis 1991;144: 1026-1032.
7. Lane SJ, Lee TH. Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid resistant bronchial asthma. Am Rev Respir Dis 1991;143:1020-1024.
8. Alvarez J, Surs W, Leung DY, et al. Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992;89:714-721.
9. Kamada AK, Leung DY, Gleason MC, et al. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. J Allergy Clin Immunol 1992;90:685-687.
10. Saetta M, Thiene G, Cresciolli S, et al. Fatal asthma in young patients with severe bronchial hyperresponsiveness but stable peak flow records. Eur Respir J 1989;2:1008-1012.
11. Matsuse H, Terufumi S, Shigeru K, et al. A clinical study of mortality due to asthma. Ann Allergy, Asthma and Immunol 1995;74:267-272.
12. Expert Panel Report 2, Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health. National Heart, Lung, and Blood Institute. NIH Publication No. 97-4051, July, 1997.
13. Okayama M, Yafuso N, Nogami H, et al. A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. J Allergy Clin Immunol 1987; 80:291-299.
14. Takishima T, Hida W, Sasaki H, et al. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981;80: 600-606.
15. Chai H, Farr RS, Froehlick LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-327.
16. Takishima T, Hida W, Suzuki S, et al. Direct graphical recordings of the cumulative dose-response curves of the airway to methacholine in normal, bronchitic and asthmayic subjects. Tohoku J Exp Med 1981;135:117-137.
17. Ishii M, Hida W, Suzuki S, et al. Comparison of intermittent and continuous inhalation provocation tests. Ann Allergy 1989;62:223-228.
18. Mitsuhashi M, Tajima K, Tokuyama K, et al. Application of a new direct-writing recorder device, the astograph to the evaluation of methacholine-induced bronchoconstriction in asthmatic children. J Asthma 1984;21: 89-95.
19. Mochizuki H, Mitsuhashi M, Shigeta M, et al. Bronchial hyperresponsiveness in children with atopic and nonatopic asthma. J Asthma 1987;24: 75-80.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
21. Bhagat RG, Grunstein MM. Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children. Am Rev Respir Dis 1985; 131:902-906.
22. Spahn JD, Leung DYM, Surs W, et al. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am J Respir Crit Care Med 1995;151:1709-1714.
23. Zimmerman B, Lanner A, Enander I, et al. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993;2:564-570.
24. ten Hacken NH, Oosterhoff Y, Kauffman HF, et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J 1998;11:312-316.
25. Corrigan CJ, Hartnell A, Kay AB. T-lymphocyte activation in acute severe asthma. Lancet 1988;i:1129-1131.
26. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis 1990;141:970-977.
27. Lopez AF, Sanderson CJ, Gamble JR, et al. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-224.
28. Kita H, Weiler DA, Abu-Ghazaleh R, et al. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992;149:629-635.
29. Leung DYM, Martin RJ, Szefler SJ, et al. Dysregulation of interleukin 4, interleukin 5, and interferon-γ gene expression in steroid-resistant asthma. J Exp Med 1995;181:33-40.
30. Adcock IM, Lane SJ, Brown CR, et al. Abnormal glucocorticoid receptor-activator 1 interaction in steroid-resistant asthma. J Exp Med 1995;182: 1951-1958.